The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study
- PMID: 30604054
- DOI: 10.1007/s00415-018-9164-5
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study
Abstract
The aim of this study was to evaluate the effect of cognitive reserve (CR), in progression from subjective cognitive decline (SCD) to mild cognitive impairment (MCI) and Alzheimer's disease (AD). For this purpose, we followed up 263 patients (154 SCD; 109 MCI) for a mean time of 7 years. CR was assessed by the Test di Intelligenza Breve (TIB), functionally equivalent to the National Adult Reading Test. High CR resulted as a protective factor for progression from SCD to MCI. Age at conversion to MCI was delayed 9 years on average in SCD with high CR with respect to SCD with low CR. On the contrary, high CR resulted as a risk factor for progression from MCI to AD dementia only in APOE ε4 carriers. Conversion time from MCI to AD dementia was 3 years shorter in ε4 carriers with high CR than subjects with low CR and ε4 non-carriers with high CR. Consistent with the CR hypothesis, our results showed that higher levels of CR protect against the earliest clinical manifestations of AD. In line with the previous researches, we found an interaction between CR and APOE in progression from MCI to AD dementia.
Keywords: APOE; Alzheimer’s disease; Cognitive reserve; Mild cognitive impairment; Neuropsychology; Subjective cognitive decline.
Similar articles
-
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.J Alzheimers Dis. 2018;63(4):1523-1535. doi: 10.3233/JAD-171180. J Alzheimers Dis. 2018. PMID: 29782316
-
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):471-482. doi: 10.1007/s00406-019-01069-y. Epub 2019 Sep 27. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31560105
-
Cognitive Reserve, Brain Reserve, APOEɛ4, and Cognition in Individuals with Subjective Cognitive Decline in the SILCODE Study.J Alzheimers Dis. 2020;76(1):249-260. doi: 10.3233/JAD-200082. J Alzheimers Dis. 2020. PMID: 32444543
-
Imaging and cognitive reserve studies predict dementia in presymptomatic Alzheimer's disease subjects.Neurodegener Dis. 2014;13(2-3):157-9. doi: 10.1159/000353690. Epub 2013 Aug 7. Neurodegener Dis. 2014. PMID: 23942061 Review.
-
Genome research in pre-dementia stages of Alzheimer's disease.Expert Rev Mol Med. 2016 May 30;18:e11. doi: 10.1017/erm.2016.12. Expert Rev Mol Med. 2016. PMID: 27237222 Review.
Cited by
-
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder.Sci Rep. 2021 Aug 2;11(1):15583. doi: 10.1038/s41598-021-95131-2. Sci Rep. 2021. PMID: 34341419 Free PMC article.
-
The Effect of CAG Repeats within the Non-Pathological Range in the HTT Gene on Cognitive Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.Diagnostics (Basel). 2021 Jun 7;11(6):1051. doi: 10.3390/diagnostics11061051. Diagnostics (Basel). 2021. PMID: 34200421 Free PMC article.
-
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.Neurology. 2024 Mar 26;102(6):e208053. doi: 10.1212/WNL.0000000000208053. Epub 2024 Feb 20. Neurology. 2024. PMID: 38377442 Free PMC article.
-
The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup.Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):941-952. doi: 10.1007/s00406-022-01516-3. Epub 2022 Nov 21. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36416960 Free PMC article.
-
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.BMC Neurol. 2023 Aug 12;23(1):300. doi: 10.1186/s12883-023-03347-8. BMC Neurol. 2023. PMID: 37573339 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous